Delivery Order SPE2DR25D2106-SPE2DR26F1FVK
Award Date 11/25/25
Potential Completion Date 11/26/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,002.66 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count) on November 3, 2025, with completion expected by November 4, 2025. This firm fixed price contract represents a non-set-aside, competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Febuxostat 80 mg tablets in quantities of 30, with a contract ceiling value of $1,191.79. This is a firm fixed price delivery order with an ultimate completion date of August 21, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.30 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units) on October 30, 2025, with completion targeted for October 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.23 to AmerisourceBergen Drug Corp for the supply of Febuxostat 80 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was executed on September 8, 2025, with an ultimate completion date of September 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,928.62 to AmerisourceBergen Drug Corp for the supply of Febuxostat 40 mg tablets (30-count units). This firm fixed-price, competitively awarded contract was issued on November 20, 2025, with an ultimate completion date of November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of Febuxostat 80 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $6,529.09. This non-set-aside award was competitively procured and is set for completion by June 27, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of Febuxostat 40 mg tablets (30-count units) under a firm fixed-price contract valued at $1,676.71. The contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.999 billion through December 2026), was competitively awarded with no set-aside designation. Performance will be executed from...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Febuxostat 80 mg tablets (30-count units) with a contract value of $2,965.04. The contract features firm fixed pricing and carries an ultimate completion date of August 26, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Febuxostat 40 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,436.92 and features firm fixed pricing, with an ultimate completion date of November 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,633.20 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Febuxostat 80 mg tablets (30-count packages). This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The work will be performed at the vendor's corporate office in Conshohocken,...